Matthew P Heckman, MD, PHD | |
103 Forestview Ave, Elkland, PA 16920-1403 | |
(814) 258-5117 | |
(814) 258-5510 |
Full Name | Matthew P Heckman |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 103 Forestview Ave, Elkland, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669738654 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 281344-1 (New York) | Secondary |
207Q00000X | Family Medicine | MD458866 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Matthew P Heckman, MD, PHD 103 Forestview Ave, Elkland, PA 16920-1403 Ph: (814) 258-5117 | Matthew P Heckman, MD, PHD 103 Forestview Ave, Elkland, PA 16920-1403 Ph: (814) 258-5117 |
News Archive
The German Research Foundation has approved a new proposal for a collaborative research center under the leadership of the Institute for Experimental Cardiovascular Medicine at the University Heart Centre Freiburg ยท Bad Krozingen.
How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control.
The grim effects that climate change will have on pediatric health outcomes was the focus of a "Viewpoint" article published in the Journal of Clinical Investigation by Susan E. Pacheco, MD, an expert at The University of Texas Health Science Center at Houston.
Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases and TARA Biosystems, Inc. a company offering "heart-on-a-chip" tissue models for drug discovery and risk assessment applications, announced today the launch of a collaboration to discover and develop novel therapies for cardiac disease and diseases associated with cardiac muscle aging.
A team of scientists from the University of California Santa Cruz, USA, recently identified a novel variant (B.1.x) of SARS-CoV-2 that might be circulating in at least 20 US states and six countries globally.
› Verified 2 days ago